Rapid complete remission in multiple myeloma with bortezomib/thalidomide/dexamethasone combination therapy following development of tumor lysis syndrome

By Chim C.  

Cancer Chemotherapy and Pharmacology, Vol. 62, Iss. 1, 2008-06 ,pp. : 181-182

Springer Publishing Company

Access to resources Recommend Favorite

Pegylated liposomal doxorubicin in combination chemotherapy in the treatment of previously untreated aggressive diffuse large-B-cell lymphoma

By Avilés Agustin   Neri Natividad   Castañeda Claudia   Talavera Alejandra   Huerta-Guzmán Judith   González Martha  

Medical Oncology, Vol. 19, Iss. 1, 2002-03 ,pp. : 55-58

Humana Press, Inc

Access to resources Recommend Favorite

Response of Previously Untreated Metastatic Rhabdomyosarcoma to Combination Chemotherapy with Carboplatin, Epirubicin and Vincristine

By on behalf of the MMT Working Party of the International Society of Paediatric Oncologists   Frascella E.   Pritchard-Jones K.   Modak S.   Mancini A.F.   Carli M.   Pinkerton C.R.  

European Journal of Cancer, Vol. 32, Iss. 5, 1996-05 ,pp. : 821-825

Elsevier

Access to resources Recommend Favorite

Use of melphalan, thalidomide, and dexamethasone in treatment of refractory and relapsed multiple myeloma

By Srkalovic Gordan   Elson Paul   Trebisky Beth   Karam Mary   Hussein Mohamad  

Medical Oncology, Vol. 19, Iss. 4, 2002-12 ,pp. : 219-226

Humana Press, Inc

Access to resources Recommend Favorite

Effective combination therapy of bortezomib and dexamethasone for a plasma cell leukemia patient with multiple osteolytic lesions and extramedullary involvement

By Capalbo Silvana   Chiefa Antonia   Delia Mario   Diomede Daniela   Liso Vincenzo  

Acta Oncologica, Vol. 46, Iss. 2, 2007-01 ,pp. : 262-264

Informa Healthcare

Access to resources Recommend Favorite